Further reduction in mortality following myocardial infarction
- PMID: 12422496
- DOI: 10.12968/hosp.2002.63.10.1933
Further reduction in mortality following myocardial infarction
Abstract
Omacor is a new omega-3 fatty acid product that is licensed for secondary prevention post-myocardial infarction. It confers an additional 20% reduction in all-cause mortality, based on the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico prevenzione (GISSI-P) study data. The GISSI-P results are compared with other trials of secondary prevention.
Similar articles
-
Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.Lipids. 2001;36 Suppl:S119-26. doi: 10.1007/s11745-001-0694-8. Lipids. 2001. PMID: 11837985 Clinical Trial.
-
Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).Ital Heart J. 2000 Dec;1(12):810-20. Ital Heart J. 2000. PMID: 11302109 Clinical Trial.
-
Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial.Circulation. 2007 Dec 18;116(25):2944-51. doi: 10.1161/CIRCULATIONAHA.107.712976. Epub 2007 Dec 3. Circulation. 2007. PMID: 18056527
-
The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardio (GISSI)-Prevenzione Trial on fish oil and vitamin E supplementation in myocardial infarction survivors.Curr Cardiol Rep. 2000 Sep;2(5):445-51. doi: 10.1007/s11886-000-0059-5. Curr Cardiol Rep. 2000. PMID: 10980913 Review.
-
Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.Adv Ther. 2009 Jul;26(7):675-90. doi: 10.1007/s12325-009-0045-2. Epub 2009 Jul 27. Adv Ther. 2009. PMID: 19629408 Review.
Cited by
-
A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction.Pharmacoeconomics. 2006;24(8):783-95. doi: 10.2165/00019053-200624080-00005. Pharmacoeconomics. 2006. PMID: 16898848
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical